once at full production-how will multiples change for Aurora"Aphria trades at more than 40 times sales. Aurora Cannabis trades at over 67 times sales. Canopy Growth is the "cheap" stock, with its share price at 34 times sales. These are all multiples that would be typically viewed as stratospheric valuations if they applied to earnings, not sales"
i have a theory but wondering on what others are thinking? im of the opinion that it would be beneficial for the company to release such projections in their forward looking statements in order to help me make informed calculated investment decisions. if anyone has come across such data can you send me an FYI feedback.